BIOLINERX
RSS
RSS
| Careers | Contact Us
search

Investor relations home

BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.

BioLineRx's close ties with universities, research institutes, academic institutions, technology transfer offices and biotech... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
06/01/15
BioLineRx will present at LD Micro Invitational Conference in Los Angeles, CA, on June 1, 2015 at 1 pm PDT
06/12/15
BioLineRx will deliver two presentations at the 20th Congress of the European Hematology Association on Friday, June 12 and Sunday, June 14, 2015 in Vienna, Austria
06/23/15
BioLineRx will present at the 9th Annual JMP Securities Life Sciences Conference on June 23, 2015
06/24/15
BioLineRx will attend the 2nd Annual ROTH Healthcare Corporate Access Day in London on June 24, 2015
09/08/15
BioLineRx presenting at The Rodman & Renshaw 17th Annual Global Investment Conference September 8-10, 2015
What's new
DateTitle
04/15/15
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types